Ranch Capital Advisors Inc. Eli Lilly & CO Transaction History

Ranch Capital Advisors Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 08, 2022	SELL	$224.85 - $279.04 $32,603 - $40,460	-145 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$221.6 - $272.71 $221 - $272	1 Added 0.69%	145 $33,000
Q4 2020 Feb 16, 2021	BUY	$130.46 - $172.63 $130 - $172	1 Added 0.7%	144 $24,000
Q1 2020 May 12, 2020	SELL	$119.05 - $147.35 $5,952 - $7,367	-50 Reduced 25.91%	143 $19,000
Q4 2019 Feb 13, 2020	BUY	$106.92 - $132.43 $20,635 - $25,558	193 New	193 $25,000

4,007

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Ranch Capital Advisors Inc., based on Form 13F filings with the SEC.

Stay updated on Ranch Capital Advisors Inc. with notifications on news.